Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K.
about
The tumor marker Fascin is induced by the Epstein-Barr virus-encoded oncoprotein LMP1 via NF-κB in lymphocytes and contributes to their invasive migrationIdentification of transmembrane protein 134 as a novel LMP1-binding protein by using bimolecular fluorescence complementation and an enhanced retroviral mutagenEmerging therapeutic strategies for Epstein-Barr virus+ post-transplant lymphoproliferative disorderRoles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implicationsEBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas.Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinomaDevelopments in Burkitt's lymphoma: novel cooperations in oncogenic MYC signaling.Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy.Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivoSrc kinase and Syk activation initiate PI3K signaling by a chimeric latent membrane protein 1 in Epstein-Barr virus (EBV)+ B cell lymphomas.Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis.LMP1 strain variants: biological and molecular properties.Induction of interferon-stimulated genes on the IL-4 response axis by Epstein-Barr virus infected human b cells; relevance to cellular transformation.Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L.Upregulation of endocan by Epstein-Barr virus latent membrane protein 1 and its clinical significance in nasopharyngeal carcinoma.The role of PI3K/Akt in human herpesvirus infection: From the bench to the bedsideChanges in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3.Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.The Epstein-Barr Virus BART microRNAs target the pro-apoptotic protein Bim.Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) and LMP2A function cooperatively to promote carcinoma development in a mouse carcinogenesis model.Infection of Epstein-Barr virus in a gastric carcinoma cell line induces anchorage independence and global changes in gene expressionUnique signaling properties of CTAR1 in LMP1-mediated transformation.Modulation of MicroRNA Cluster miR-183-96-182 Expression by Epstein-Barr Virus Latent Membrane Protein 1Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript RegionThe viral oncoprotein LMP1 exploits TRADD for signaling by masking its apoptotic activity.Epstein-Barr virus LMP1 modulates lipid raft microdomains and the vimentin cytoskeleton for signal transduction and transformationEpstein-Barr virus latent membrane protein 1 represses DNA repair through the PI3K/Akt/FOXO3a pathway in human epithelial cells.EBV latent membrane protein 1 effects on plakoglobin, cell growth, and migration.Tumor-derived variants of Epstein-Barr virus latent membrane protein 1 induce sustained Erk activation and c-FosPursuing different 'TRADDes': TRADD signaling induced by TNF-receptor 1 and the Epstein-Barr virus oncoprotein LMP1.Epstein-Barr virus latent membrane protein-1 effects on junctional plakoglobin and induction of a cadherin switch.LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells.Mouse model for acute Epstein-Barr virus infection.Role of the Epstein-Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma.Characterization of the latent membrane protein 1 signaling complex of Epstein-Barr virus in the membrane of mammalian cells with bimolecular fluorescence complementation.Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3.Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Upregulates Glucose Transporter 1 Transcription via the mTORC1/NF-κB Signaling Pathways.CD63 Regulates Epstein-Barr Virus LMP1 Exosomal Packaging, Enhancement of Vesicle Production, and Noncanonical NF-κB Signaling.Epstein-Barr virus LMP1 induces focal adhesions and epithelial cell migration through effects on integrin-α5 and N-cadherin.LMP1 Increases Expression of NADPH Oxidase (NOX) and Its Regulatory Subunit p22 in NP69 Nasopharyngeal Cells and Makes Them Sensitive to a Treatment by a NOX Inhibitor.
P2860
Q21146664-E55CF65F-B497-4B23-A678-0EA2A0ED873AQ24633907-5158B246-6FE5-4858-AED9-2649314C0656Q26859114-03B3FEE3-D97A-4A0F-9736-F9696176F051Q27009016-768E4CAF-FC4E-4222-BAD0-DCDA60607D6CQ30837949-90B519D0-A498-45F5-A770-3699B750433DQ33818584-AE73560C-5C88-48D7-A072-F6DDEA721A52Q34039568-E6FB7BCE-3A35-4626-89D4-5032F6C605BBQ34171822-23F3B9EF-FE67-4E3B-A0EC-3F79F9134C1BQ34353826-51F3B90A-40C9-4CE7-8B2E-318CA3AC1EBFQ34374436-32C645C0-7FFF-4002-ABE6-34D4BB9D64D9Q34611577-5B81C8EA-0F2B-4841-9E51-3D0C51AFFD78Q34717145-C58DD8E6-1B6A-415A-934E-E400526C478DQ34749867-E4B4B60E-D5CC-4476-A3FD-00EFCF45078AQ35032548-937566C8-0D17-43A3-8570-F994BF0D79C6Q35067738-315761FD-D818-441A-9FB1-606F250221FCQ35582498-26A1B550-0E82-42F9-A6D5-B13094613591Q35677629-CFE3466A-9BB5-4E6B-98B8-B32C25E052A1Q35861281-454F5A8E-E3AE-48D8-97CD-CCE7BE202D3CQ35924384-995AB232-FEE8-4713-B2F1-52E3C1EDB1ABQ35943724-8EFA0B59-771F-4AA5-A1C5-719E9131B828Q36066487-996CB755-EE06-459F-9F11-24A9604ADB38Q36098869-6C22163A-5733-4210-A921-CD862F7CC53AQ36281174-8DB157E2-2101-4B54-AC18-1932CD24B450Q36281868-36128640-9BDF-47A2-AD25-77F8691BFEC6Q36327896-EA47B54A-F0C0-4885-9137-CB5D5BD84937Q36559750-A5DF985A-BEBB-4CEB-AF53-6CC1781A26C9Q36845616-6139CF5A-71D1-4257-9CD3-16F4A6268C1CQ36994005-826CE152-E98A-4E40-870A-8BADD64CB0BBQ37021555-0D04AFA9-14A1-45C9-AD62-1D7A368229C5Q37247067-3CBF71BC-89B0-4555-B03A-E8218D9D1FE8Q37408369-A62E5B1F-BF1C-41DC-BCAD-4DE119FD7E5EQ37414197-89A75D4A-E669-4804-8A86-D8EA63818454Q37473875-8A6F8C53-D48D-427D-8F9A-57DAEE264D27Q37575613-73BEEC93-1B9A-4BD5-9A19-D2DDB47C897FQ38427527-EAF36803-EC4A-4A8C-829C-BAE2AD2D9727Q38610363-392B56A0-ACCD-420D-AAB1-63FE6DEFFFB2Q38722933-636E6D69-4F87-4A6F-96B4-EFDE8D23CB76Q38782732-1F266F90-DDE9-4732-8605-B354C944A198Q38826798-57AF9A7D-8CBC-43CA-A2A6-0491C592F33BQ38846183-40866A06-8CF3-4D3E-9E76-F9D1D0788B71
P2860
Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Epstein-Barr virus latent memb ...... on through activation of PI3K.
@en
type
label
Epstein-Barr virus latent memb ...... on through activation of PI3K.
@en
prefLabel
Epstein-Barr virus latent memb ...... on through activation of PI3K.
@en
P2093
P2860
P356
P1433
P1476
Epstein-Barr virus latent memb ...... on through activation of PI3K.
@en
P2093
Bernardo A Mainou
David N Everly
Nancy Raab-Traub
P2860
P2888
P304
P356
10.1038/SJ.ONC.1208846
P407
P577
2005-10-01T00:00:00Z
P5875
P6179
1036477146